Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Former Medco exec Blyskal joins GSI

Executive Summary

Former Medco Exec VP-Operations & Technology Robert Blyskal joins e-commerce company GSI Commerce as chief operating officer. GSI supports retail e-commerce sites but does not participate in the pharmaceutical sector. Blyskal left Medco after David Snow took over as CEO in March 2003. Several of the allegations in "whistleblower" suits pending against Medco identify Blyskal by name (1"The Pink Sheet" Oct. 6, 2003, p. 32)...

You may also be interested in...



A Tale Of Two Cities: Medco Admits Past Problems In Tampa, Dallas

Medco believes it has addressed record-keeping problems uncovered at its Tampa and Dallas pharmacies by changing the top executives at each facility

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044066

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel